• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 7132
Medical Device Problem Codes Break (1069); Difficult to Advance (2920)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/20/2023
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that shaft break occurred.The 90% stenosed target lesion was located in the tortuous and heavily calcified middle of left anterior descending artery.A 2.50mm x 12mm emerge balloon catheter was advanced for dilatation.However, resistance was noticed during delivery of the device, and the shaft of the balloon fractured.The device was removed with the catheter as one unit.The procedure was completed with no patient complications nor injuries reported.
 
Additional Manufacturer Narrative
Device evaluated by mfr.: returned product consisted of an incomplete emerge mr balloon catheter.The device was visually and microscopically examined.The total returned portion of the device was 62.6cm of which a portion of the hypotube, the strain relief and hub of the device failed to return.The hypotube was separated at the most proximal end of the returned portion.There were numerous kinks to the hypotube of the device.There was blood within the guidewire lumen and the balloon folds.The balloon was tightly folded.Product analysis confirmed the reported separation as there was a hypotube separation to the device.Product analysis could not confirm the reported difficulty to advance, as the clinical circumstances could not be replicated; however, there were numerous kinks to the hypotube of the device.
 
Event or Problem Description
It was reported that shaft break occurred.The 90% stenosed target lesion was located in the tortuous and heavily calcified middle of left anterior descending artery.A 2.50mm x 12mm emerge balloon catheter was advanced for dilatation.However, resistance was noticed during delivery of the device, and the shaft of the balloon fractured.The device was removed with the catheter as one unit.The procedure was completed with no patient complications nor injuries reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EMERGE
Common Device Name
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key17232308
Report Number2124215-2023-34043
Device Sequence Number12537089
Product Code LOX
UDI-Device Identifier08714729806103
UDI-Public08714729806103
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
K113220
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 08/18/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date11/12/2025
Device Model Number7132
Device Catalogue Number7132
Device Lot Number0031221986
Was Device Available for Evaluation? Device Returned to Manufacturer
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 06/20/2023
Supplement Date Received by Manufacturer08/17/2023
Initial Report FDA Received Date06/29/2023
Supplement Report FDA Received Date08/18/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/13/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-